Varicella vaccine
Varicella Vaccine
5
Physician Attitudes Regarding Breakthrough Varicella Disease and a Potential Second Dose of Varicella Vaccine
9
POTENTIAL BARRIERS TO IMMUNIZATION WITH VARICELLA VACCINE
8
Application of a Live Varicella Vaccine in Children With Acute Leukemia or Other Malignant Diseases
7
Safety of Second-Dose Single-Antigen Varicella Vaccine
10
Evaluation of Efficacy of Varicella Vaccine in Pediatric Patients with Acute lymphoblastic Leukemia
7
Varicella zoster virus seroprevalence in children and adolescents in the pre varicella vaccine era, Germany
9
Recommendations for the Use of Live Attenuated Varicella Vaccine
8
Five-Year Follow-up Study of Recipients of Live Varicella Vaccine Using Enhanced Neutralization and Fluorescent Antibody Membrane Antigen Assays
6
Global Varicella Vaccine Effectiveness: A Meta-analysis
12
Varicella-Like Illness Caused by Live Varicella Vaccine in Children With Acute Lymphocytic Leukemia
8
Varicella Vaccine: A Point of Decision
5
Postexposure Effectiveness of Varicella Vaccine
7
Genetic Profile of an Oka Varicella Vaccine Virus Variant Isolated from an Infant with Zoster
5
Modified Chickenpox in Children Immunized With the Oka/Merck Varicella Vaccine
8
Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United States
9
Global Varicella Vaccine Effectiveness: A Meta-analysis
8
Severe Varicella Caused by Varicella-Vaccine Strain in a Child With Significant T-Cell Dysfunction
7
Combination Measles, Mumps, Rubella, and Varicella Vaccine
8
Varicella Vaccine Studies in Healthy Children and Adults
11